A reassessment of the clinical utility of 68Ga-DOTATATE PET/CT in patients with gastroenteropancreatic neuroendocrine tumors

被引:0
|
作者
Prela, Orjola
Caveney, Brennen
Strawderman, Myla S.
Carpizo, Darren R.
机构
[1] Univ Rochester, Rochester, NY USA
[2] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Rochester, NY USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16294
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Impact of 68Ga-DOTATATE PET/CT on the Surgical Management of Primary Neuroendocrine Tumors of the Pancreas or Ileum
    Ilhan, Harun
    Fendler, Wolfgang P.
    Cyran, Clemens C.
    Spitzweg, Christine
    Auernhammer, Christoph J.
    Gildehaus, Franz-Josef
    Bartenstein, Peter
    Angele, Martin K.
    Haug, Alexander R.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (01) : 164 - 171
  • [42] PET/CT imaging of neuroendocrine tumors with the use of radiolabeled peptide analogues: the role of 68Ga-DOTATATE
    Vangu, M.
    Mkhize, N.
    Louw, L.
    Purbhoo, K.
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56
  • [43] 68Ga-DOTATATE PET/CT in the Initial Diagnosis of Patients With Clinical, Imaging, and/or Biochemical Suspicion of a Neuroendocrine Tumor
    Metser, Ur
    Ezzat, Shereen
    Singh, Simron
    Myrehaug, Sten
    Rahimi, Shiva
    Gray, Daryl
    Singnurkar, Amit
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (11) : 933 - 936
  • [44] A Comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in Pulmonary Neuroendocrine Tumors
    Kayani, Irfan
    Conry, Brendon G.
    Groves, Ashley M.
    Win, Thida
    Dickson, John
    Caplin, Martyn
    Bomanji, Jamshed B.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (12) : 1927 - 1932
  • [45] The Combined Interpretation of 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT in Metastatic Gastroenteropancreatic Neuroendocrine Tumors A Classification System With Prognostic Impact
    Hayes, Aimee R.
    O'Mahony, Luke Furtado
    Quigley, Ann-Marie
    Gnanasegaran, Gopinath
    Caplin, Martyn E.
    Navalkissoor, Shaunak
    Toumpanakis, Christos
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (01) : 26 - 35
  • [46] Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective
    Herrmann, Ken
    Czernin, Johannes
    Wolin, Edward M.
    Gupta, Pawan
    Barrio, Martin
    Gutierrez, Antonio
    Schiepers, Christiaan
    Mosessian, Sherly
    Phelps, Michael E.
    Allen-Auerbach, Martin S.
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (01) : 70 - 75
  • [47] Primary Neuroendocrine Tumor of the Ileostomy Stoma on 68Ga-DOTATATE PET/CT
    Yu, Lei
    Braun, Alexander
    Hansen, Neil J.
    Downey, Ryan T.
    Johnson, Craig M.
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (06) : 463 - 464
  • [48] Brain Metastases of a Neuroendocrine Tumor Visualized by 68Ga-DOTATATE PET/CT
    Hoberueck, Sebastian
    Michler, Enrico
    Zoephel, Klaus
    Platzek, Ivan
    Kotzerke, Joerg
    Brogsitter, Claudia
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (01) : 50 - 52
  • [49] 68Ga-FAPI PET/CT Versus 68Ga-DOTATATE PET/CT in the Evaluation of a Patient With Neuroendocrine Tumor
    Komek, Halil
    Gundogan, Cihan
    Can, Canan
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (05) : E290 - E292
  • [50] Quantification of immunohistochemical expression of somatostatin receptors in neuroendocrine tumors using 68Ga-DOTATATE PET/CT
    Haug, A. R.
    Assmann, G.
    Rist, C.
    Tiling, R.
    Schmidt, G. P.
    Bartenstein, P.
    Hacker, M.
    RADIOLOGE, 2010, 50 (04): : 349 - 354